{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:46:45Z","timestamp":1758991605963,"version":"3.35.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,29]]},"DOI":"10.7759\/cureus.78212","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:38:38Z","timestamp":1738215518000},"source":"Crossref","is-referenced-by-count":1,"title":["Prescription Pattern of Laxatives for Opioid-Induced Constipation in Japanese Patients With Chronic Non-cancer Pain: A Retrospective Cohort Study of a Health Insurance Claims Database"],"prefix":"10.7759","author":[{"given":"Motoki","family":"Sonohata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misato","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-770","article-title":"Pain as a global public health priority","volume":"11","author":"Goldberg DS","year":"2011","unstructured":"Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011, 11:770. 10.1186\/1471-2458-11-770","journal-title":"BMC Public Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129262","article-title":"Chronic pain in the Japanese community--prevalence, characteristics and impact on quality of life","volume":"10","author":"Inoue S","year":"2015","unstructured":"Inoue S, Kobayashi F, Nishihara M, et al.. Chronic pain in the Japanese community--prevalence, characteristics and impact on quality of life. PLoS One. 2015, 10:e0129262. 10.1371\/journal.pone.0129262","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01187.x","article-title":"Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states","volume":"12","author":"Fine PG","year":"2011","unstructured":"Fine PG. Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Med. 2011, 12:996-1004. 10.1111\/j.1526-4637.2011.01187.x","journal-title":"Pain Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S105892","article-title":"A review of chronic pain impact on patients, their social environment and the health care system","volume":"9","author":"Due\u00f1as M","year":"2016","unstructured":"Due\u00f1as M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res. 2016, 9:457-67. 10.2147\/JPR.S105892","journal-title":"J Pain Res"},{"key":"ref5","unstructured":"International Association for the Study of Pain. Preventing pain. an introduction. (2021). Accessed: March 13, 2024: https:\/\/www.iasp-pain.org\/resources\/fact-sheets\/preventing-pain-an-introduction\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic non-cancer pain. A systematic review and meta-analysis","volume":"320","author":"Busse JW","year":"2018","unstructured":"Busse JW, Wang L, Kamaleldin M, et al.. Opioids for chronic non-cancer pain. A systematic review and meta-analysis. JAMA. 2018, 320:2448-60. 10.1001\/jama.2018.18472","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X15578608","article-title":"Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities","volume":"8","author":"Nelson AD","year":"2015","unstructured":"Nelson AD, Camilleri M. Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities. Therap Adv Gastroenterol. 2015, 8:206-20. 10.1177\/1756283X15578608","journal-title":"Therap Adv Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000170","article-title":"Opioid-induced hyperalgesia in community-dwelling adults with chronic pain","volume":"156","author":"Hooten WM","year":"2015","unstructured":"Hooten WM, Lamer TJ, Twyner C. Opioid-induced hyperalgesia in community-dwelling adults with chronic pain. Pain. 2015, 156:1145-52. 10.1097\/j.pain.0000000000000170","journal-title":"Pain"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-014-1452-0","article-title":"[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]","volume":"29","author":"H\u00e4user W","year":"2015","unstructured":"H\u00e4user W, Bernardy K, Maier C. [Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]. Schmerz. 2015, 29:96-108. 10.1007\/s00482-014-1452-0","journal-title":"Schmerz"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso E","year":"2004","unstructured":"Kalso E, Edwards JE, Moore AR, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004, 112:372-80. 10.1016\/j.pain.2004.09.019","journal-title":"Pain"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12724","article-title":"Opioid-induced constipation among patients with chronic non-cancer pain in the United States, Canada, Germany, and the United Kingdom: laxative use, response, and symptom burden over time","volume":"16","author":"Coyne KS","year":"2015","unstructured":"Coyne KS, Margolis MK, Yeomans K, King FR, Chavoshi S, Payne KA, LoCasale RJ. Opioid-induced constipation among patients with chronic non-cancer pain in the United States, Canada, Germany, and the United Kingdom: laxative use, response, and symptom burden over time. Pain Med. 2015, 16:1551-65. 10.1111\/pme.12724","journal-title":"Pain Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/ajgsup.2014.7","article-title":"Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach","volume":"2","author":"Dorn S","year":"2014","unstructured":"Dorn S, Lembo A, Cremonini F. Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach. Am J Gastroenterol Suppl. 2014, 2:31-7. 10.1038\/ajgsup.2014.7","journal-title":"Am J Gastroenterol Suppl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2012.28792","article-title":"The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities","volume":"16","author":"Leppert W","year":"2012","unstructured":"Leppert W. The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities. Contemp Oncol (Pozn). 2012, 16:125-31. 10.5114\/wo.2012.28792","journal-title":"Contemp Oncol (Pozn)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5056\/jnm23144","article-title":"Opioid-induced constipation: old and new concepts in diagnosis and treatment","volume":"30","author":"Squeo F","year":"2024","unstructured":"Squeo F, Celiberto F, Ierardi E, et al.. Opioid-induced constipation: old and new concepts in diagnosis and treatment. J Neurogastroenterol Motil. 2024, 30:131-42. 10.5056\/jnm23144","journal-title":"J Neurogastroenterol Motil"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-022-00392-y","article-title":"A survey of the incidence of constipation in patients with chronic non-cancer pain using opioid analgesics in Japan","volume":"11","author":"Sonohata M","year":"2022","unstructured":"Sonohata M, Wada S, Koretaka Y, Morioka Y, Mishima H, Mawatari M. A survey of the incidence of constipation in patients with chronic non-cancer pain using opioid analgesics in Japan. Pain Ther. 2022, 11:845-59. 10.1007\/s40122-022-00392-y","journal-title":"Pain Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2023.2267441","article-title":"Recommendations for the management of opioid-induced constipation - how to improve usability in clinical practice","volume":"17","author":"Okdahl T","year":"2023","unstructured":"Okdahl T, Emmanuel A, Morlion B, Farmer A, Varrassi G, Drewes AM. Recommendations for the management of opioid-induced constipation - how to improve usability in clinical practice. Expert Rev Gastroenterol Hepatol. 2023, 17:975-83. 10.1080\/17474124.2023.2267441","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American Gastroenterological Association Institute guideline on the medical management of opioid-induced constipation","volume":"156","author":"Crockett SD","year":"2019","unstructured":"Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S. American Gastroenterological Association Institute guideline on the medical management of opioid-induced constipation. Gastroenterology. 2019, 156:218-26. 10.1053\/j.gastro.2018.07.016","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement","volume":"7","author":"Farmer AD","year":"2019","unstructured":"Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O'Brien T, Morlion B, Tack J. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterol J. 2019, 7:7-20. 10.1177\/2050640618818305","journal-title":"United European Gastroenterol J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2021.0438","article-title":"Revision of pharmacological treatment recommendations for cancer pain: clinical guidelines from the Japanese Society of Palliative Medicine","volume":"25","author":"Mawatari H","year":"2022","unstructured":"Mawatari H, Shinjo T, Morita T, Kohara H, Yomiya K. Revision of pharmacological treatment recommendations for cancer pain: clinical guidelines from the Japanese Society of Palliative Medicine. J Palliat Med. 2022, 25:1095-114. 10.1089\/jpm.2021.0438","journal-title":"J Palliat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-023-00520-2","article-title":"A nationwide hospital claims database analysis of real-world patterns of laxative use for opioid-induced constipation in Japanese patients with cancer","volume":"12","author":"Higashibata T","year":"2023","unstructured":"Higashibata T, Kessoku T, Morioka Y, et al.. A nationwide hospital claims database analysis of real-world patterns of laxative use for opioid-induced constipation in Japanese patients with cancer. Pain Ther. 2023, 12:993-1003. 10.1007\/s40122-023-00520-2","journal-title":"Pain Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jgf2.422","article-title":"Data resource profile: JMDC claims database sourced from health insurance societies","volume":"22","author":"Nagai K","year":"2021","unstructured":"Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T. Data resource profile: JMDC claims database sourced from health insurance societies. J Gen Fam Med. 2021, 22:118-27. 10.1002\/jgf2.422","journal-title":"J Gen Fam Med"},{"key":"ref22","unstructured":"JMDC real world. (2024). Accessed. March 13, 2024: https:\/\/www.eng.phm-jmdc.com\/."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199141030-00002","article-title":"Opioid agonist-antagonist drugs in acute and chronic pain states","volume":"41","author":"Hoskin PJ","year":"1991","unstructured":"Hoskin PJ, Hanks GW. Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs. 1991, 41:326-44. 10.2165\/00003495-199141030-00002","journal-title":"Drugs"},{"key":"ref24","unstructured":"Japanese Society for Palliative Medicine. Clinical guidelines for cancer pain management. (2020). Accessed. March 13, 2024: https:\/\/www.jspm.ne.jp\/files\/guideline\/pain2020.pdf."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/2050640616659967","article-title":"Prevalence and clinical features of opioid-induced constipation in the general population: a French study of 15,000 individuals","volume":"5","author":"Ducrott\u00e9 P","year":"2017","unstructured":"Ducrott\u00e9 P, Milce J, Soufflet C, Fabry C. Prevalence and clinical features of opioid-induced constipation in the general population: a French study of 15,000 individuals. United European Gastroenterol J. 2017, 5:588-600. 10.1177\/2050640616659967","journal-title":"United European Gastroenterol J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.genm.2009.04.007","article-title":"Gender differences in self-reported constipation characteristics, symptoms, and bowel and dietary habits among patients attending a specialty clinic for constipation","volume":"6","author":"McCrea GL","year":"2009","unstructured":"McCrea GL, Miaskowski C, Stotts NA, Macera L, Paul SM, Varma MG. Gender differences in self-reported constipation characteristics, symptoms, and bowel and dietary habits among patients attending a specialty clinic for constipation. Gend Med. 2009, 6:259-71. 10.1016\/j.genm.2009.04.007","journal-title":"Gend Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04996-7","article-title":"More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer","volume":"28","author":"Roeland EJ","year":"2020","unstructured":"Roeland EJ, Sera CJ, Ma JD. More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer. Support Care Cancer. 2020, 28:1793-7. 10.1007\/s00520-019-04996-7","journal-title":"Support Care Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5056\/jnm18194","article-title":"A randomized double-blind placebo-controlled trial on the effect of magnesium oxide in patients with chronic constipation","volume":"25","author":"Mori S","year":"2019","unstructured":"Mori S, Tomita T, Fujimura K, et al.. A randomized double-blind placebo-controlled trial on the effect of magnesium oxide in patients with chronic constipation. J Neurogastroenterol Motil. 2019, 25:563-75. 10.5056\/jnm18194","journal-title":"J Neurogastroenterol Motil"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/308565-prescription-pattern-of-laxatives-for-opioid-induced-constipation-in-japanese-patients-with-chronic-non-cancer-pain-a-retrospective-cohort-study-of-a-health-insurance-claims-database","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:38:43Z","timestamp":1738215523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/308565-prescription-pattern-of-laxatives-for-opioid-induced-constipation-in-japanese-patients-with-chronic-non-cancer-pain-a-retrospective-cohort-study-of-a-health-insurance-claims-database"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.78212","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}